Vistin Pharma is strongly committed to maintaining an open dialogue with our shareholders, potential investors, analysts, investment banks and the financial markets.

Our goal is for the share price to reflect the underlying value of the company by providing all price-relevant information to the market.
Last updated 29.03 2022 11:00
Nok 16,80
Since open-0,30 (-1.70%)
Since previous close +0,44 (+2.60%)

8 reasons for investing in Vistin Pharma ASA.

Leading Producer
Amongst Top 5 producers of metformin HCl globally
High Quality Reputation
Leading reputation as producer of high quality APIs with strong track record of customer delivery
Attractive Market Dynamics
Established position in growing metformin market
Diverse Client Portfolio
Established client base comprising mix of Big Pharma and leading generics players
Sustained Revenue Growth
Strong growth profile with double digit revenue growth in the last 5 years
Advanced Manufacturing Facilities
State of the art and dedicated manufacturing facility with potential for further expansion
Strong Leadership
Experienced management team with a strong track record
A Front-runner
Leading the ESG culture in the industry

Quarterly Results

Annual Reports

Other downloads

Investor calendar

16.2.24
Q4 2023 Quarterly report
24.4.24
2023 Annual Report
24.4.24
Q1 Quarterly report
23.5.24
Annual General Meeting
23.8.24
Q2 and Half-Yearly report
31.10.24
Q3 Quarterly Report

Main shareholders

NAME

Per 31st January 2024

SHAREHOLDING

% SHARE

1
INTERTRADE SHIPPING AS*
12 575 000
28,40 %
2
HOLMEN SPESIALFOND
3 842 055
8,50 %
3
PACTUM AS*
3 519 733
7,90 %
4
MP PENSJON PK
1 719 848
3,90 %
5
FERNCLIFF LISTED DAI AS*
1 234 280
2,80 %
6
STORKLEIVEN AS
751 000
1,70 %
7
AUGUST RINGVOLD AGENTUR AS
750 315
1,70 %
8
LUCELLUM AS
720 000
1,60 %
9
HENRIK MIDTTUN HAAVIE
601 516
1,40 %
10
IVAR LØGES STIFTELSE
550 000
1,20 %
11
TOM RAGNAR PRESTEGÅRD STAAVI
526 324
1,20 %
12
CORTEX AS
508 989
1,10 %
13
WEM INVEST AS
500 000
1,10 %
14
DNB BANK ASA
488 464
1,10 %
15
SANDEN EQUITY AS
468 947
1,10 %
16
DELTA AS
410 000
0,90 %
17
GINKO AS
400 000
0,80 %
18
ØYSTEIN STRAY SPETALEN*
323 650
0,70 %
19
NIELS CATO BECKETT AALL
301 658
0,70 %
20
NICOLAI ANDREAS EGER
284 040
0,64 %
Total 20 largest shareholders
30 446 255
68,70 %
Other shareholders
13 898 337
31,30 %
Total number of shares
44 344 592
100%
* Board members of Vistin Pharma, or companies controlled by Board members
Vistin Pharma - Oslo Stock Exchange

Contact

Alexander Karlsen
CFO
Vistin Pharma ASA
+47 970 53 621alexander.karlsen@vistin.com
Alexander Karlsen